In a commentary published in the journal Nature, experts called for a stronger global response in tackling antibiotic resistant bacteria. These pathogens, such as methicillin-resistant staphylococcus aureus (MRSA) which cannot be treated with the most powerful drugs on the market, are now in every corner of the world and pose a significant health threat to humans. Experts want to create an independent body to oversee a coordinated international effort to develop new drugs and set targets to reduce antibiotic use.
In some countries, more than half of people infected with bacteria won’t respond to carbapenems. A similar percentage of patients with infections won’t be helped by taking fluoroquinolone antibiotics.